Skinbutak Go Young Magiccream

Description

The product is a cream formulation intended for topical application. It is identified by the SPL Code 34089-3. The active ingredients are not specified in the provided information, and the inactive ingredients are also not listed.

Uses and Indications

This drug is indicated for topical application to the skin. It should be applied gently along the skin texture in an appropriate amount.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The recommended dosage for achieving soft, brighter, and revitalized skin is to apply the product as directed by a healthcare professional. The application should be performed topically, ensuring that the skin is clean and dry prior to use.

For optimal results, the product should be applied once or twice daily, depending on the individual's skin type and sensitivity. A pea-sized amount is typically sufficient for each application, which should be gently massaged into the skin until fully absorbed.

Healthcare professionals should advise patients to monitor their skin's response to the treatment and adjust the frequency of application as necessary. It is important to instruct patients to avoid contact with the eyes and mucous membranes, and to wash hands thoroughly after application.

In cases of irritation or adverse reactions, patients should discontinue use and consult a healthcare professional for further guidance.

Contraindications

Application of this product is contraindicated in the following situations:

The product should not be applied to wounds or damaged skin due to the potential for adverse effects. Additionally, it is contraindicated to bandage tightly, as this may lead to complications. Care should also be taken to avoid contact with the eyes, as exposure could result in irritation or injury.

Warnings and Precautions

For external use only. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following occur: the condition worsens, symptoms persist for more than 7 days, or symptoms resolve and then recur within a few days.

It is crucial to avoid application on wounds or damaged skin to prevent adverse effects. Additionally, patients should be instructed not to apply a tight bandage over the treated area, as this may lead to complications.

Side Effects

Patients should be aware that the product is intended for external use only. In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Participants are advised to discontinue use and consult a healthcare professional if any of the following occur: the condition worsens, symptoms persist for more than 7 days, or symptoms resolve and then recur within a few days. Additionally, the product should not be applied to wounds or damaged skin, and it is important to avoid tight bandaging of the area where the product is applied.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Skinbutak Go Young Magiccream (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. There are no specific age ranges, dosage differences, or study outcomes provided for pediatric use in the available data. Caution is advised when administering this medication to ensure safety in the pediatric population.

Geriatric Use

There is no specific information regarding the use of SKINBUTAK GO YOUNG MAGIC CREAM in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this product to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable in this population, given the lack of established guidelines for geriatric use.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There is no specific information available regarding the use of this medication in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to the nursing infant.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, it is imperative to seek immediate medical assistance. Healthcare professionals should advise patients or caregivers to contact a Poison Control Center without delay if the substance has been ingested.

Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is essential. Prompt recognition of symptoms can facilitate timely intervention and management.

Management of overdosage should be guided by the clinical presentation and may include supportive care and symptomatic treatment. Continuous monitoring of the patient's vital signs and overall status is recommended to ensure appropriate responses to any emerging complications.

In all cases of suspected overdosage, the involvement of poison control and emergency medical services is crucial to ensure optimal outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion or misuse. Patients should be instructed to stop using the product and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms clear up and then recur within a few days, patients should also seek medical advice.

It is important to inform patients not to apply the product to wounds or damaged skin, as this may lead to adverse effects. Patients should be cautioned against tightly bandaging the area where the product is applied, as this could exacerbate potential side effects. Furthermore, healthcare providers should emphasize the importance of avoiding contact with the eyes while using this product, as it may cause irritation or injury.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

The route of administration for the product is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Skinbutak Go Young Magiccream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)